| __timestamp | Cytokinetics, Incorporated | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 17268000 | 5496000 |
| Thursday, January 1, 2015 | 19667000 | 9786000 |
| Friday, January 1, 2016 | 27823000 | 6792000 |
| Sunday, January 1, 2017 | 36468000 | 7313000 |
| Monday, January 1, 2018 | 31282000 | 8382000 |
| Tuesday, January 1, 2019 | 39610000 | 10803000 |
| Wednesday, January 1, 2020 | 52820000 | 12944000 |
| Friday, January 1, 2021 | 96803000 | 21967000 |
| Saturday, January 1, 2022 | 177977000 | 32810000 |
| Sunday, January 1, 2023 | 173612000 | 46542000 |
Infusing magic into the data realm
In the competitive world of biotechnology, managing operational costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of Cytokinetics, Incorporated and Xenon Pharmaceuticals Inc. from 2014 to 2023. Over this period, Cytokinetics has seen a dramatic increase in SG&A expenses, growing by over 900%, from approximately $17 million in 2014 to nearly $174 million in 2023. In contrast, Xenon Pharmaceuticals has experienced a more modest rise, with expenses increasing by around 750%, from $5.5 million to $46.5 million. This divergence highlights the differing strategies and growth trajectories of these two companies. Cytokinetics' aggressive expansion is evident in its higher expenditure, while Xenon's steady growth reflects a more conservative approach. Understanding these trends provides valuable insights into the operational strategies of leading biotech firms.
Operational Costs Compared: SG&A Analysis of AstraZeneca PLC and Xenon Pharmaceuticals Inc.
Selling, General, and Administrative Costs: Gilead Sciences, Inc. vs Xenon Pharmaceuticals Inc.
Alnylam Pharmaceuticals, Inc. vs Cytokinetics, Incorporated: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Cytokinetics, Incorporated
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Xenon Pharmaceuticals Inc.
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
Who Optimizes SG&A Costs Better? Walgreens Boots Alliance, Inc. or Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Cytokinetics, Incorporated and Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Breaking Down SG&A Expenses: Perrigo Company plc vs Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. vs MorphoSys AG: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Xenon Pharmaceuticals Inc. and Agios Pharmaceuticals, Inc.